Fecal Microbiota Transplantation News and Research

RSS

Researchers develop new method of encapsulating fecal bacteria to treat serious intestinal infection

Clostridioides difficile infection causes severe diarrhea and results in the death of nearly 20,000 patients in Europe each year. It is one of the most common hospital-acquired infections. When it relapses, the disease must be treated by fecal microbiota transplantation.

10 May 2023

Fecal microbiota transplant: Effective solution for recurrent C. difficile infections

Researchers provide an overview of fecal microbiota transplantation in treating recurrent Clostridioides difficile infection.

27 Apr 2023

Uncovering the connection between the microbiome and aging

Researchers evaluated the recent advances in understanding how the microbiome influences aging and associated diseases.

15 Apr 2023

Exploring the gut microbiome's role in rheumatoid arthritis pathogenesis

Researchers analyzed data on the association between intestinal microbiome dysbiosis and rheumatoid arthritis.

6 Apr 2023

Can fecal microbiota be administered safely and efficiently to prevent Clostridiodes difficile infection?

Researchers assessed the safety and efficacy of fecal microbiota in preventing Clostridiodes difficile infection.

6 Apr 2023

What role does dysbiosis play in Parkinson's disease?

The current study, published in the journal Revue Neurologique, is based on the hypothesis that dysbiosis, or unhealthy variations in the gut and oral microbiota, is a key component of PD pathogenesis.

19 Mar 2023

Gut dysbiosis and sepsis susceptibility among pregnant women

Researchers describe the role of gut dysbiosis during pregnancy in promoting excessive macrophage pyroptosis, which increases vulnerability to sepsis.

19 Feb 2023

What do gut microbiota have to do with Alzheimer's and dementia?

Researchers explore the preventive and therapeutic potential of gut microbiome modulation in the treatment of Alzheimer’s disease.

6 Feb 2023

Using the gut microbiome to understand and treat respiratory diseases

Researchers review the role of the gut microbiome in certain respiratory diseases.

22 Dec 2022

What is the role of the pediatric gut microbiome in COVID-19?

Recently, scientists have reviewed the available evidence on the gut microbiome in children with COVID-19 and published it in Microorganisms.

15 Dec 2022

The compositional and functional diversity of the gut fungal microbiome

Researchers assessed the role of gut bacterial microbiome assembly and the gut mycobiome in relation to health, pathology, and clinical applications.

30 Sep 2022

Higher levels of microbiota engraftment linked to greater chances of transplantation success

From incurable intestinal infections to metabolic syndrome, from melanoma, to chronic inflammatory bowel disease, such as irritable bowel syndrome, to Tourette's syndrome: many diseases can potentially be cured by Fecal Microbiota Transplantation (FMT), and researchers from the Catholic University, Rome and the University of Trento have shown that the greater the level of engraftment of the transplanted microorganisms, the greater the chances of success of the therapy.

15 Sep 2022

Understanding what happens when two gut microbiomes clash together

Fecal microbiota transplantation (FMT) – the transfer of lower intestinal fluids and microbes from one individual to another – is sometimes used to treat inflammatory gut diseases, including ulcerative colitis and bacterial infections.

15 Sep 2022

New perspectives on C-section and microbiota in newborns

A new study pinpoints key questions and knowledge gaps that must be addressed in order to define microbiome deficits and their link to health outcomes in infants born by Cesarian section, but also to evaluate adequate clinical intervention strategies in this population.

22 Jun 2022

Fecal microbiota transplant shows durable effect in treating irritable bowel syndrome

A new study discusses the efficacy of fecal transplant in patients with IBS three years after the procedure was performed.

16 Jun 2022

Fecal Microbiota Transplantation found to be an optimal cost-effective treatment for recurrent C. difficile infection

Research recently published in Clinical Infectious Diseases from the University of Minnesota Medical School has found that Fecal Microbiota Transplantation, or FMT, is an optimal cost-effective treatment for first recurrent Clostridioides difficile infection, or CDI or C-Diff.

3 Jun 2022

Fecal Microbiota Transplantation News and Research

Researchers develop new method of encapsulating fecal bacteria to treat serious intestinal infection

Fecal microbiota transplant: Effective solution for recurrent C. difficile infections

Uncovering the connection between the microbiome and aging

Exploring the gut microbiome's role in rheumatoid arthritis pathogenesis

Can fecal microbiota be administered safely and efficiently to prevent Clostridiodes difficile infection?

What role does dysbiosis play in Parkinson's disease?

Gut dysbiosis and sepsis susceptibility among pregnant women

What do gut microbiota have to do with Alzheimer's and dementia?

Using the gut microbiome to understand and treat respiratory diseases

What is the role of the pediatric gut microbiome in COVID-19?

The compositional and functional diversity of the gut fungal microbiome

Higher levels of microbiota engraftment linked to greater chances of transplantation success

Understanding what happens when two gut microbiomes clash together

New perspectives on C-section and microbiota in newborns

Fecal microbiota transplant shows durable effect in treating irritable bowel syndrome

Fecal Microbiota Transplantation found to be an optimal cost-effective treatment for recurrent C. difficile infection

Studying immunomodulatory effects of microbiota helps design prophylactic and therapeutic interventions against COVID-19

UVA research sheds light on why fecal transplant can benefit patients with C. difficile infections

Small set of beneficial bacterial strains linked to effectiveness of fecal microbiota transplants

New dietary fiber formulation improves the potency of cancer immunotherapies

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

Bridging the Gap between Academia and Industry: The Power of Collaboration in Life Sciences

Revolutionizing Schizophrenia Research

Latest News